Author:
Park Hyun Kyung,Kim Su Kang
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,General Pharmacology, Toxicology and Pharmaceutics,Toxicology,Pathology and Forensic Medicine
Reference29 articles.
1. Vignozzi, L. et al. Benign prostatic hyperplasia: a new metabolic disease? J Endocrinol Invest 37:313–322 (2014).
2. Untergasser, G., Madersbacher, S. & Berger, P. Benign prostatic hyperplasia: age-related tissue-remodeling. Exp Gerontol 40:121–128 (2005).
3. Patel, N. D. & Parsons, J. K. Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian J Urol 30:170–176 (2014).
4. Pan, J. G., Liu, M. & Zhou, X. Relationship between lower urinary tract symptoms and metabolic syndrome in a Chinese male population. J Endocrinol Invest 37: 339–344 (2014).
5. Culig, Z. Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer. J Endocrinol Invest Epub ahead of print (2015).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献